Synonyms: CS-747 | Effient® | Efient®
prasugrel is an approved drug (FDA and EMA (2009))
Compound class:
Synthetic organic
Comment: This drug is metabolised to its active metabolite R-138727.
Marketed formulations may contain prasugrel hydrochloride (PubChem CID 10158453). View more information in the IUPHAR Pharmacology Education Project: prasugrel |
|
No information available. |
Mechanism Of Action and Pharmacodynamic Effects |
R-138727 is an antagonist of the P2Y12 receptor, which is an adenosine diphosphate (ADP) receptor expressed on platelets. ADP-induced activation of P2Y12 causes platelet aggregation and promotes blood clot formation. Antagonism of ADP binding inhibits these effects. |
External links |
For extended ADME data see the following: Electronic Medicines Compendium (eMC) Drugs.com European Medicines Agency (EMA) |